{"id":"W3038225256","doi":"10.1093/cid/ciaa935","title":"Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development","year":2020,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kelowna General Hospital","funders":"","keywords":"Commit; Clinical trial; Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Computer science; Internal medicine; Disease; Infectious disease (medical specialty)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003633308,0.0001987549,0.0008805102,0.0000739537,0.0008261874,0.0002437569,0.0002024912,0.000152142,0.0001235327],"category_scores_gemma":[0.07410935,0.0001898041,0.0003681573,0.0002698571,0.00002372803,0.0004285734,0.0000879958,0.0002047371,0.00002802718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001087343,"about_ca_system_score_gemma":0.0004905756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002995576,"about_ca_topic_score_gemma":0.007135627,"domain_scores_codex":[0.9957718,0.001364435,0.001648006,0.000518552,0.0002761765,0.0004210096],"domain_scores_gemma":[0.9888401,0.01006082,0.0004721529,0.0001653534,0.0002188578,0.0002427093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001687084,0.0009910683,0.9402224,0.0001235878,0.0001249065,0.00005450716,0.003666812,0.00003908955,0.0002823691,0.00236464,0.005655793,0.04630612],"study_design_scores_gemma":[0.01634468,0.003899773,0.9012017,0.0005352547,0.0006413365,0.000001539163,0.002265636,0.0007038685,0.0008084044,0.008078312,0.06376015,0.001759315],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953011,0.0004414198,0.0001941493,0.002000666,0.0002995731,0.001194958,0.00001898399,0.0002030767,0.0003461021],"genre_scores_gemma":[0.9952037,0.0001780257,0.0002280153,0.002429132,0.001676691,0.0002020494,0.0000250781,0.00002635422,0.00003098126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07047604,"threshold_uncertainty_score":0.9336898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6391396753229814,"score_gpt":0.5608644386210478,"score_spread":0.07827523670193359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}